Literature DB >> 23620698

Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy.

Naranjan S Dhalla1, Shashanka Rangi, Shelley Zieroth, Yan-Jun Xu.   

Abstract

Although diabetes due to insulin deficiency or insulin resistance is a major cause of heart disease, the pathogenesis of cardiac dysfunction during the development of diabetic cardiomyopathy is not fully understood. Varying degrees of defects in subcellular organelles, such as sarcolemma, mitochondria, sarcoplasmic reticulum, myofibrils and extracellular matrix have been observed in the diabetic heart. These subcellular abnormalities in chronic diabetes become evident with the occurrence of hormonal imbalance, metabolic defects, oxidative stress and intracellular Ca(2+) overload. During the initial stages of diabetes, hormonal imbalances, including elevated plasma levels of catecholamines and angiotensin II, as well as metabolic defects, appear to favour the development of oxidative stress; these changes lead to subcellular defects in the myocardium. Reductions in sarcoplasmic reticular Ca(2+) pump and Ca(2+) release channel function are associated with cardiac dysfunction, whereas alterations in sarcolemmal Na(+)/Ca(2+) exchanger and Na(+)/K(+) ATPase activities contribute to intracellular Ca(2+) overload at late stages of diabetes. The continued accumulation of Ca(2+) in mitochondria produces Ca(2+) overload in these organelles, and this change induces impairment of energy production and depletion of energy stores as well as further promotion of oxidative stress in chronic diabetes. Generation of oxyradicals due to impaired electron transport results in the opening of mitochondrial pores, leakage of toxic proteins and myocardial cell damage in diabetes. These observations support the view that alterations in sarcoplasmic reticular and mitochondrial functions produce intracellular Ca(2+) overload and depletion of energy stores and, thus, play an important role in the development of cardiac dysfunction in diabetic cardiomyopathy.

Entities:  

Keywords:  Diabetic cardiomyopathy; Mitochondria; Sarcoplasmic reticulum; Subcellular remodelling

Year:  2012        PMID: 23620698      PMCID: PMC3628423     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  95 in total

1.  Diabetes decreases Na+-K+ pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat.

Authors:  K Kjeldsen; H Braendgaard; P Sidenius; J S Larsen; A Nørgaard
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

2.  Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis.

Authors:  D B Ostrander; G C Sparagna; A A Amoscato; J B McMillin; W Dowhan
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

3.  Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats.

Authors:  L S Golfman; N Takeda; N S Dhalla
Journal:  Diabetes Res Clin Pract       Date:  1996-07       Impact factor: 5.602

4.  Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.

Authors:  Xiao-Yan Zhao; Shen-Jiang Hu; Jiang Li; Yun Mou; Bao-Ping Chen; Qiang Xia
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 4.158

5.  Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

Authors:  Jennifer G Duncan; Juliet L Fong; Denis M Medeiros; Brian N Finck; Daniel P Kelly
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

6.  Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.

Authors:  Darrell D Belke; Eric A Swanson; Wolfgang H Dillmann
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Myocardial composition and function in diabetes. The effects of chronic insulin use.

Authors:  T J Regan; C F Wu; C K Yeh; H A Oldewurtel; B Haider
Journal:  Circ Res       Date:  1981-12       Impact factor: 17.367

10.  Beneficial effects of verapamil in diabetic cardiomyopathy.

Authors:  N Afzal; P K Ganguly; K S Dhalla; G N Pierce; P K Singal; N S Dhalla
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

View more
  14 in total

1.  Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Authors:  Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

Review 2.  Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Nirankar S Neki; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 3.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

4.  The effects of zofenopril on cardiac function and pro-oxidative parameters in the streptozotocin-induced diabetic rat heart.

Authors:  Petar Ristic; Ivan Srejovic; Tamara Nikolic; Isidora Stojic; Dragana Ristic; Vladimir Zivkovic; Vladimir Lj Jakovljevic
Journal:  Mol Cell Biochem       Date:  2016-11-24       Impact factor: 3.396

Review 5.  Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.

Authors:  Raphael M Singh; Tahreem Waqar; Frank C Howarth; Ernest Adeghate; Keshore Bidasee; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

6.  Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy.

Authors:  Zhukovska Anna; Shysh Angela; Bacova Barbara; Radosinska Jana; Benova Tamara; Viczenczova Csilla; Dosenko Victor; Moybenko Oleksiy; Tribulova Narcisa
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

7.  Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats.

Authors:  Zhongshu Liang; Sunnar Leo; Helin Wen; Mao Ouyang; Weihong Jiang; Kan Yang
Journal:  BMC Cardiovasc Disord       Date:  2015-05-13       Impact factor: 2.298

8.  Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium.

Authors:  C Fernandez-Sanz; M Ruiz-Meana; E Miro-Casas; E Nuñez; J Castellano; M Loureiro; I Barba; M Poncelas; A Rodriguez-Sinovas; J Vázquez; D Garcia-Dorado
Journal:  Cell Death Dis       Date:  2014-12-18       Impact factor: 8.469

Review 9.  The Role of Cardiolipin in Cardiovascular Health.

Authors:  Zheni Shen; Cunqi Ye; Keanna McCain; Miriam L Greenberg
Journal:  Biomed Res Int       Date:  2015-08-02       Impact factor: 3.411

10.  N-Acetyl Cysteine improves the diabetic cardiac function: possible role of fibrosis inhibition.

Authors:  Cong Liu; Xiao-Zhao Lu; Ming-Zhi Shen; Chang-Yang Xing; Jing Ma; Yun-You Duan; Li-Jun Yuan
Journal:  BMC Cardiovasc Disord       Date:  2015-08-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.